| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
135,801 |
128,315 |
$27.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,738 |
43,577 |
$9.42M |
| 31622 |
|
1,911 |
1,696 |
$5.93M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
2,417 |
2,175 |
$4.88M |
| 99218 |
|
5,015 |
2,910 |
$2.93M |
| 76770 |
|
10,377 |
9,640 |
$2.02M |
| 71046 |
Radiologic examination, chest; 2 views |
12,218 |
11,344 |
$1.96M |
| 64642 |
|
1,909 |
1,752 |
$1.79M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,490 |
10,397 |
$1.62M |
| 99221 |
|
2,370 |
2,130 |
$1.62M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,062 |
6,291 |
$1.25M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
810 |
726 |
$1.13M |
| 94375 |
|
10,399 |
9,769 |
$1.13M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,954 |
4,794 |
$1.01M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,009 |
4,179 |
$847K |
| 16020 |
|
3,666 |
2,531 |
$805K |
| J0475 |
Injection, baclofen, 10 mg |
625 |
575 |
$766K |
| 95990 |
|
611 |
560 |
$523K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,655 |
2,355 |
$500K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,461 |
6,030 |
$478K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,934 |
1,485 |
$472K |
| 92567 |
|
8,217 |
7,414 |
$451K |
| 59025 |
Fetal non-stress test |
1,446 |
1,152 |
$432K |
| 72082 |
|
4,258 |
3,946 |
$410K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
703 |
650 |
$399K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
701 |
623 |
$373K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
643 |
415 |
$372K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
68 |
55 |
$294K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,166 |
1,690 |
$255K |
| 95700 |
|
513 |
423 |
$241K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,228 |
2,067 |
$232K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,763 |
22,217 |
$179K |
| 31526 |
|
815 |
705 |
$178K |
| 92604 |
|
1,378 |
1,211 |
$171K |
| 51600 |
|
179 |
155 |
$146K |
| 92555 |
|
2,580 |
2,364 |
$137K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,281 |
1,066 |
$135K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,286 |
1,065 |
$134K |
| 80053 |
Comprehensive metabolic panel |
13,525 |
11,692 |
$127K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,248 |
1,138 |
$114K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
165 |
157 |
$104K |
| 95951 |
|
184 |
149 |
$100K |
| 73130 |
|
1,891 |
1,632 |
$99K |
| 51784 |
|
380 |
343 |
$97K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,124 |
4,774 |
$97K |
| 36415 |
Collection of venous blood by venipuncture |
27,619 |
24,483 |
$95K |
| 90947 |
|
1,530 |
75 |
$95K |
| 95716 |
|
370 |
244 |
$91K |
| 74018 |
|
499 |
461 |
$86K |
| 72170 |
|
1,975 |
1,863 |
$82K |
| 76825 |
|
209 |
189 |
$79K |
| 51729 |
|
86 |
76 |
$73K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,295 |
1,258 |
$64K |
| 76820 |
|
890 |
664 |
$57K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
19 |
17 |
$56K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,419 |
696 |
$51K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
483 |
426 |
$51K |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
101 |
97 |
$46K |
| 90937 |
|
422 |
74 |
$43K |
| 36591 |
|
359 |
264 |
$41K |
| 62369 |
|
85 |
80 |
$36K |
| 16025 |
|
127 |
93 |
$36K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
821 |
761 |
$33K |
| 72081 |
|
658 |
602 |
$31K |
| 87503 |
|
1,134 |
1,040 |
$31K |
| 77073 |
|
615 |
589 |
$30K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,161 |
1,058 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,373 |
912 |
$27K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
798 |
251 |
$25K |
| 92552 |
|
216 |
189 |
$25K |
| 64644 |
|
54 |
44 |
$24K |
| 83970 |
|
1,863 |
1,035 |
$24K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
135 |
114 |
$23K |
| 82728 |
|
2,772 |
2,149 |
$22K |
| 93325 |
|
1,501 |
1,278 |
$22K |
| 97763 |
|
382 |
255 |
$22K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
147 |
137 |
$20K |
| 82977 |
|
2,873 |
2,422 |
$19K |
| 83735 |
|
4,430 |
3,042 |
$19K |
| 92602 |
|
137 |
111 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
398 |
181 |
$18K |
| 86923 |
|
30 |
12 |
$17K |
| 92579 |
|
532 |
488 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,769 |
2,593 |
$16K |
| 73070 |
|
382 |
335 |
$16K |
| 80348 |
|
107 |
94 |
$16K |
| 94060 |
|
153 |
147 |
$15K |
| 85045 |
|
4,896 |
3,872 |
$15K |
| 96409 |
|
176 |
107 |
$15K |
| 92522 |
|
82 |
79 |
$14K |
| 83550 |
|
2,572 |
1,970 |
$13K |
| 31541 |
|
29 |
29 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
808 |
767 |
$13K |
| 83020 |
|
920 |
722 |
$12K |
| 84100 |
|
3,693 |
2,241 |
$11K |
| 83540 |
|
2,638 |
2,030 |
$10K |
| 93975 |
|
14 |
13 |
$10K |
| 87276 |
|
907 |
863 |
$10K |
| 36430 |
|
27 |
25 |
$9K |
| 73110 |
|
148 |
137 |
$9K |
| 81001 |
|
3,788 |
3,413 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
63 |
57 |
$9K |
| 87275 |
|
907 |
863 |
$8K |
| 92593 |
|
181 |
148 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
46 |
44 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
113 |
102 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
664 |
630 |
$8K |
| 92526 |
|
81 |
66 |
$7K |
| 80061 |
Lipid panel |
692 |
593 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
488 |
448 |
$7K |
| 80069 |
|
911 |
733 |
$6K |
| 31231 |
|
75 |
70 |
$6K |
| 81002 |
|
2,843 |
2,543 |
$6K |
| 74019 |
|
26 |
25 |
$6K |
| 97167 |
|
38 |
38 |
$6K |
| 73090 |
|
144 |
125 |
$6K |
| 84439 |
|
689 |
650 |
$6K |
| 80197 |
|
491 |
362 |
$6K |
| 49452 |
|
16 |
14 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
572 |
550 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
80 |
69 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
86 |
80 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
26 |
24 |
$5K |
| 92587 |
|
458 |
428 |
$5K |
| 82550 |
|
769 |
609 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34 |
32 |
$4K |
| 94200 |
|
39 |
38 |
$4K |
| 85027 |
|
1,691 |
1,145 |
$4K |
| 97760 |
|
163 |
155 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
97 |
92 |
$4K |
| 96450 |
|
20 |
12 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,613 |
875 |
$4K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
15 |
13 |
$4K |
| 85610 |
|
926 |
850 |
$4K |
| 86317 |
|
34 |
12 |
$3K |
| J9370 |
Vincristine sulfate, 1 mg |
166 |
97 |
$3K |
| 31599 |
|
59 |
42 |
$3K |
| 97542 |
|
65 |
57 |
$3K |
| 82784 |
|
224 |
153 |
$3K |
| 73552 |
|
54 |
50 |
$3K |
| 85652 |
|
953 |
887 |
$2K |
| 73080 |
|
38 |
36 |
$2K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
15 |
12 |
$2K |
| 87497 |
|
57 |
24 |
$2K |
| 36592 |
|
24 |
12 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
68 |
30 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
17 |
13 |
$2K |
| 83516 |
|
235 |
144 |
$2K |
| 92553 |
|
14 |
12 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
13 |
12 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
17 |
$2K |
| 85730 |
|
299 |
275 |
$2K |
| 86481 |
|
35 |
32 |
$2K |
| 86140 |
|
331 |
302 |
$2K |
| 77075 |
|
14 |
12 |
$2K |
| 80050 |
General health panel |
14 |
13 |
$2K |
| J1756 |
Injection, iron sucrose, 1 mg |
174 |
26 |
$2K |
| 82570 |
|
472 |
322 |
$2K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
19 |
18 |
$2K |
| 86357 |
|
38 |
25 |
$1K |
| 86355 |
|
36 |
25 |
$1K |
| 96415 |
|
15 |
12 |
$1K |
| 86003 |
|
55 |
41 |
$1K |
| 84075 |
|
1,240 |
785 |
$1K |
| 73590 |
|
25 |
24 |
$1K |
| 86359 |
|
51 |
25 |
$1K |
| 80074 |
|
30 |
27 |
$1K |
| 92592 |
|
20 |
16 |
$974.39 |
| 81003 |
|
518 |
389 |
$958.87 |
| 96381 |
|
40 |
34 |
$958.82 |
| 82248 |
|
198 |
184 |
$953.47 |
| 84450 |
|
1,189 |
741 |
$940.36 |
| 77072 |
|
45 |
39 |
$932.49 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
192 |
186 |
$929.42 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
12 |
$926.10 |
| 73610 |
|
14 |
13 |
$922.63 |
| 86803 |
|
263 |
154 |
$907.68 |
| 84156 |
|
292 |
236 |
$896.12 |
| 87400 |
|
122 |
104 |
$879.89 |
| 80076 |
|
111 |
88 |
$814.09 |
| 93320 |
|
286 |
250 |
$808.92 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
41 |
12 |
$765.45 |
| 86850 |
|
144 |
124 |
$689.49 |
| 73630 |
|
14 |
13 |
$634.50 |
| 82108 |
|
101 |
63 |
$598.12 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
103 |
58 |
$558.12 |
| 87340 |
|
145 |
97 |
$527.63 |
| 82103 |
|
46 |
39 |
$509.00 |
| 82785 |
|
28 |
26 |
$494.41 |
| 86706 |
|
128 |
81 |
$489.04 |
| 86901 |
|
159 |
137 |
$442.09 |
| 86900 |
|
159 |
137 |
$442.09 |
| 92595 |
|
15 |
14 |
$415.95 |
| 94726 |
|
18 |
14 |
$394.98 |
| 86708 |
|
32 |
32 |
$388.62 |
| 82810 |
|
14 |
12 |
$346.06 |
| 80305 |
|
27 |
25 |
$323.43 |
| 83655 |
|
30 |
28 |
$304.70 |
| 81025 |
|
55 |
50 |
$303.01 |
| 86704 |
|
104 |
60 |
$276.83 |
| 82040 |
|
483 |
281 |
$271.99 |
| 84520 |
|
284 |
175 |
$260.19 |
| 94770 |
|
25 |
25 |
$252.33 |
| 82610 |
|
15 |
14 |
$198.06 |
| 82104 |
|
17 |
14 |
$154.87 |
| 83051 |
|
21 |
12 |
$144.94 |
| 84460 |
|
152 |
92 |
$121.57 |
| 82247 |
|
148 |
90 |
$105.22 |
| 84155 |
|
156 |
93 |
$80.60 |
| 83690 |
|
14 |
14 |
$65.92 |
| 82330 |
|
87 |
30 |
$55.98 |
| 82465 |
|
14 |
13 |
$53.26 |
| 84550 |
|
12 |
12 |
$49.58 |
| 76937 |
|
12 |
12 |
$42.14 |
| 85347 |
|
25 |
12 |
$31.90 |
| 85014 |
|
13 |
12 |
$14.27 |
| 0064U |
|
33 |
30 |
$0.00 |
| C1769 |
Guide wire |
26 |
25 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
166 |
125 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
65 |
28 |
$0.00 |
| 90686 |
|
18 |
17 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
16 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
76 |
25 |
$0.00 |
| 94799 |
|
42 |
40 |
$0.00 |
| 64643 |
|
268 |
190 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
55 |
49 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
13 |
12 |
$0.00 |
| 93321 |
|
14 |
12 |
$0.00 |